NVCT
Price
$9.96
Change
-$0.37 (-3.58%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
249.12M
13 days until earnings call
UTHR
Price
$303.09
Change
+$2.33 (+0.77%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
13.34B
Earnings call today
Ad is loading...

NVCT vs UTHR

Header iconNVCT vs UTHR Comparison
Open Charts NVCT vs UTHRBanner chart's image
Nuvectis Pharma
Price$9.96
Change-$0.37 (-3.58%)
Volume$697
Capitalization249.12M
United Therapeutics
Price$303.09
Change+$2.33 (+0.77%)
Volume$11.85K
Capitalization13.34B
NVCT vs UTHR Comparison Chart
Loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVCT vs. UTHR commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a Hold and UTHR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (NVCT: $10.33 vs. UTHR: $300.76)
Brand notoriety: NVCT and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 275% vs. UTHR: 108%
Market capitalization -- NVCT: $249.12M vs. UTHR: $13.34B
NVCT [@Biotechnology] is valued at $249.12M. UTHR’s [@Biotechnology] market capitalization is $13.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 4 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • NVCT’s TA Score: 4 bullish, 4 bearish.
  • UTHR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than NVCT.

Price Growth

NVCT (@Biotechnology) experienced а +11.43% price change this week, while UTHR (@Biotechnology) price change was +2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.93%. For the same industry, the average monthly price growth was +3.53%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

NVCT is expected to report earnings on Aug 06, 2025.

UTHR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+2.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.3B) has a higher market cap than NVCT($249M). NVCT YTD gains are higher at: 90.943 vs. UTHR (-14.760). UTHR has higher annual earnings (EBITDA): 1.65B vs. NVCT (-19.85M). UTHR has more cash in the bank: 3.27B vs. NVCT (18.5M). UTHR has higher revenues than NVCT: UTHR (2.88B) vs NVCT (0).
NVCTUTHRNVCT / UTHR
Capitalization249M13.3B2%
EBITDA-19.85M1.65B-1%
Gain YTD90.943-14.760-616%
P/E RatioN/A12.21-
Revenue02.88B-
Total Cash18.5M3.27B1%
Total DebtN/A300M-
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVCTUTHR
RSI
ODDS (%)
Bearish Trend 7 days ago
76%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 10 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
CHESS.X0.0712930.002837
+4.14%
Tranchess cryptocurrency
AGIX.X0.301656-0.009718
-3.12%
SingularityNET cryptocurrency
FLOKI.X0.000084-0.000003
-3.65%
FLOKI cryptocurrency
COTI.X0.072749-0.003893
-5.08%
COTI cryptocurrency
SYN.X0.277264-0.015780
-5.38%
Synapse cryptocurrency

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and DARE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and DARE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-3.00%
DARE - NVCT
30%
Poorly correlated
+0.52%
SGMT - NVCT
29%
Poorly correlated
+3.32%
UTHR - NVCT
29%
Poorly correlated
+1.25%
PDSB - NVCT
28%
Poorly correlated
+1.61%
FTRE - NVCT
28%
Poorly correlated
+4.11%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+1.25%
DAWN - UTHR
40%
Loosely correlated
-0.78%
TECH - UTHR
38%
Loosely correlated
+0.50%
GERN - UTHR
37%
Loosely correlated
-1.43%
KRYS - UTHR
35%
Loosely correlated
+0.49%
HALO - UTHR
35%
Loosely correlated
+0.41%
More